Even Short-Term Telmisartan Treatment Ameliorated Insulin Resistance But Had No Influence on Serum Adiponectin and Tumor Necrosis Factor-Alpha Levels in Hypertensive Patients with Metabolic Syndrome-Reference-Cited by-同舟云学术

Even Short-Term Telmisartan Treatment Ameliorated Insulin Resistance But Had No Influence on Serum Adiponectin and Tumor Necrosis Factor-Alpha Levels in Hypertensive Patients with Metabolic Syndrome

Published:2019-04 Issue:3 Volume:17 Page:167-172
ISSN:1540-4196
Container-title:Metabolic Syndrome and Related Disorders
language:en
Short-container-title:Metabolic Syndrome and Related Disorders

Author:

Kiyici Sinem¹,Guclu Metin¹,Budak Ferah²,Sigirli Deniz³,Tuncel Ercan⁴

Affiliation:

1. Department of Endocrinology and Metabolism, Bursa Yuksek Ihtisas Education and Research Hospital, University of Health Sciences, Bursa, Turkey.

2. Department of Immunology, Medical Faculty, Uludag University, Bursa, Turkey.

3. Department of Bio-Statistics, and Medical Faculty, Uludag University, Bursa, Turkey.

4. Department of Endocrinology and Metabolism, Medical Faculty, Uludag University, Bursa, Turkey.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/met.2018.0129

Reference40 articles.

1. Harmonizing the Metabolic Syndrome

2. Harmonizing the Definition of the Metabolic Syndrome: Comparison of the Criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European Populations

3. What is the best biomarker for metabolic syndrome diagnosis?

4. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease

5. Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) Agonists on Glycemic Control, Lipid Profile and Cardiovascular Risk

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of telmisartan on metabolic syndrome components: a comprehensive review;Biomedicine & Pharmacotherapy;2024-02

2. PECULIARITIES OF CARBOHYDRATE METABOLISM INDICATORS, THE FUNCTIONAL STATE OF THE THYROID GLAND IN THE COURSE TREATMENT WITH TELMISARTAN AS PART OF THE COMPLEX THERAPY OF PATIENTS WITH CORONARY ARTERY DISEASE, TYPE 2 DIABETES MELLITUS ON THE BASIS OF METAB;Acta Medica Leopoliensia;2023-12-27

3. Sartans in the treatment of arterial hypertension: focus on telmisartan and azilsartan. A review;Terapevticheskii arkhiv;2023-11-03

4. The Role of Tumor Necrosis Factor-Alpha in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease;Current Obesity Reports;2023-07-05

5. Advantages of telmisartan pharmacotherapy in elderly patients with arterial hypertension and metabolic syndrome who have suffered an ischemic stroke;Cardiovascular Therapy and Prevention;2022-10-03